HIV Prevention Trials Network

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, HIV Prevention Trials Network sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).

10 total trials none currently recruiting 9 completed early-phase tilt top decile by trial count

HIV Prevention Trials Network: 10 sponsored US clinical trials, none currently recruiting.

HIV Prevention Trials Network sponsors 10 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 9 completed. 1 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is HIV Prevention, with 1 trials.

Top-decile sponsor footprint

HIV Prevention Trials Network ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Indexed trials (enrollment closed)

10 total, page 1 of 1

NOT YET RECRUITING Phase 3

Duo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy

NCT07658976
COMPLETED NA

INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit

NCT04804072
COMPLETED Phase 2

Pre-Exposure Prophylaxis for Transgender Women in the US and South America

NCT04742491
COMPLETED NA

Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected MSM in the United States

NCT02663219
COMPLETED

HPTN 073 Black Men Who Have Sex With Men (MSM) Pre-Exposure Prophylaxis (PrEP)

NCT01808352
COMPLETED Phase 2

The ADAPT Study: Use of Emtricitabine and Tenofovir Disoproxil Fumarate for Pre-Exposure Prophylaxis (PrEP)

NCT01327651
COMPLETED Phase 1

Dose-Proportionality and Intra-Individual Variability of Intracellular TFV-DP and FTC-TP in Healthy Volunteers

NCT01276600
COMPLETED NA

Evaluating Methods to Increase HIV Testing, Access to HIV Care, and HIV Prevention Strategies

NCT01152918
COMPLETED NA

Feasibility Study of a Multi-Component Intervention for Black Men Who Have Sex With Men

NCT00951249
COMPLETED

The Women's HIV SeroIncidence Study (ISIS)

NCT00995176

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 2
Phase 3 1

Therapeutic Areas

HIV Prevention 1

How the HIV Prevention Trials Network early-phase archive is shaped

10 indexed studies, none listed as recruiting (0% open); 9 completed (90%).

Phase mix: 1 late (III/IV) vs 3 early (I/II) (early-phase heavy).

Top condition: HIV Prevention (1 trial), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

HIV Prevention Trials Network: archived-pipeline peers nationwide

Peers matched on 10 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

HIV Prevention Trials Network sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40% Total trials Recruiting share HIV Prevention Trials NetworkAdamas PharmaceuticalsAdverum BiotechnologiesAevi Genomic Medicine, LLC, a Cerecor companyAgouron Pharmaceuticals10xBio22nd Century Group23andMe3-C Institute for Social Development
HIV Prevention Trials Network sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

HIV Prevention Trials Network sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 10 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this HIV Prevention Trials Network page

10 registered trials is a research-attention snapshot, not an endorsement of HIV Prevention Trials Network or any single study.

  • None of HIV Prevention Trials Network's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • HIV Prevention is the condition HIV Prevention Trials Network studies most, compare against other sponsors active in the same condition before evaluating a specific study. See HIV Prevention trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

HIV Prevention Trials Network pipeline card: 10 registered trials from official public datasets.Report a data error.